DKSH entered a strategic distribution partnership with BridgeBio
- Written by Telegraph Magazine
DKSH entered a strategic distribution partnership with BridgeBio to support regulatory evaluation and potential patient access to a Transthyretin Stabilizer for ATTR-CM in Australia, Singapore, South Korea, and Taiwan. The partnership combines BridgeBio’s biotech innovation and DKSH Healthcare’s integrated end-to-end commercialization platform to bring a new treatment option to patients.
Read more: DKSH entered a strategic distribution partnership with BridgeBio









